Iterum Therapeutics (ITRM) Insider Trading & Ownership $1.10 +0.02 (+1.39%) As of 11:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Iterum Therapeutics (NASDAQ:ITRM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.20%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$113,700.00Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$160,441.80 Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITRM Insider Buying and Selling by Quarter Iterum Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/22/2023Michael W DunneDirectorBuy25,000$1.40$35,000.00 11/22/2023Michael W DunneDirectorBuy20,000$2.03$40,600.00 11/20/2023Corey N FishmanCEOBuy10,000$1.59$15,900.00 12/2/2022Sailaja PuttaguntaInsiderSell3,365$1.32$4,441.80 9/19/2022Brenton Karl AhrensDirectorSell15,000$1.77$26,550.00 9/16/2022Brenton Karl AhrensDirectorSell15,000$1.90$28,500.00 9/14/2022Brenton Karl AhrensDirectorSell15,000$2.10$31,500.00 9/12/2022Brenton Karl AhrensDirectorSell15,000$2.31$34,650.00 9/9/2022Brenton Karl AhrensDirectorSell15,000$2.32$34,800.00 9/7/2022Michael W DunneDirectorBuy10,000$2.22$22,200.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) ITRM Insider Trading Activity - Frequently Asked Questions Who is on Iterum Therapeutics's Insider Roster? The list of insiders at Iterum Therapeutics includes Brenton Karl Ahrens, Corey N Fishman, Michael W Dunne, and Sailaja Puttagunta. Learn more on insiders at ITRM. What percentage of Iterum Therapeutics stock is owned by insiders? 9.20% of Iterum Therapeutics stock is owned by insiders. Learn more on ITRM's insider holdings. Which Iterum Therapeutics insiders have been buying company stock? The following insiders have purchased ITRM shares in the last 24 months: Corey N Fishman ($15,900.00), and Michael W Dunne ($75,600.00). How much insider buying is happening at Iterum Therapeutics? Insiders have purchased a total of 55,000 ITRM shares in the last 24 months for a total of $91,500.00 bought. Iterum Therapeutics Key ExecutivesMr. Corey N. Fishman (Age 59)President, CEO & Director Compensation: $1.3MMs. Judith M. Matthews (Age 54)Chief Financial Officer Compensation: $747.77kDr. Michael W. Dunne M.D. (Age 64)Strategic Advisor & Director Compensation: $115kDr. Sailaja Puttagunta M.D. (Age 55)Chief Medical Officer Compensation: $946.83kMr. Tom Loughman Ph.D.Senior Vice President of Technical OperationsMs. Louise BarrettSenior Vice President of Legal Affairs & SecretaryDr. Steven I. Aronin M.D.Senior VP & Head of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Puma Biotechnology Insider Trades Protara Therapeutics Insider Trades Inhibikase Therapeutics Insider Trades Nkarta Insider Trades Lyell Immunopharma Insider Trades scPharmaceuticals Insider Trades Larimar Therapeutics Insider Trades Korro Bio Insider Trades Greenwich LifeSciences Insider Trades Coherus BioSciences Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:ITRM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ITRM Stock Free ITRM Stock Alerts